Applied Therapeutics, Inc. (APLT) Financials

APLT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 54.8 million 72.0 million
2023-09-30 45.2 million 56.2 million
2023-06-30 43.6 million 48.0 million
2023-03-31 30.0 million 34.1 million

APLT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -17.0 million 1.6 million
2023-09-30 -14.7 million 1.8 million
2023-06-30 -16.5 million 1.8 million
2023-03-31 -7.0 million 2.1 million

APLT Net Income

No data available :(

APLT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 49.9 million - 467000
2023-09-30 37.5 million - 535000
2023-06-30 35.6 million - 656000
2023-03-31 22.9 million - 774000

APLT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 84.2 million
2023-09-30 90.7 million
2023-06-30 79.0 million
2023-03-31 56.4 million

APLT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 15.3 million 5.0 million -
2023-09-30 - 10.8 million 4.7 million -
2023-06-30 - 11.9 million 5.3 million -
2023-03-31 - 15.9 million 5.6 million -

APLT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 -667000 347000
2023-09-30 - 118000
2023-06-30 - 115000
2023-03-31 10.7 million 114000

APLT

Price: $4.71

52 week price:
0.76
9.39

Earnings Per Share: -1.42 USD

P/E Ratio: -2.42

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 546852

Market Capitalization: 657.6 million

Links: